Suppliers / Abbvie Ireland Nl

Abbvie Ireland Nl

Ireland Updated 9 July 2026

Abbvie Ireland Nl is an API and finished-dose manufacturer based in Ireland. It appears in 35 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and INVIMA (CO). Its GMP standing is certified by EMA and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 14 December 2022 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
35
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 December 2022 VAI US FDA
  • 28 February 2020 VAI US FDA
  • 29 August 2019 NAI US FDA
  • 20 January 2017 NAI US FDA
  • 12 September 2014 NAI US FDA
  • 24 March 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SLIGO, Ireland Not on file
Ireland, Ireland 3004364014

What they file, and where

Molecule Regulators Docs
Paricalcitol SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 22 None
MINSA (CR) 10 None
INVIMA (CO) 3 None
EMA None 4
EAEU_EEC None 1

Comparing suppliers?

Choose your molecules and target markets. Abbvie Ireland Nl comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 December 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates